Alcon (ALC) Cash from Financing Activities (2009 - 2026)
Alcon (ALC) posted Cash from Financing Activities of -$510.0 million for Q2 2026, down 283.46% on a QoQ basis from -$133.0 million in Q1 2026, and down 33.16% year-over-year from -$763.0 million in Q2 2025.
Analysis
Alcon (ALC) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Alcon has reported Cash from Financing Activities for 11 years, with the latest figure at -$510.0 million in Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 33.16% year-over-year to -$510.0 million in Q2 2026; TTM through Jun 2026 was -$1.3 billion, a 100.78% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 billion, down 247.52% from the prior year.
- Cash from Financing Activities was -$510.0 million for Q2 2026 at Alcon, down from -$133.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $281.0 million in Q4 2022, with the low at -$510.0 million in Q2 2026.
- Average Cash from Financing Activities over 5 years is -$129.8 million, with a median of -$89.0 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities soared 951.52% in 2022, then tumbled 8150.0% in 2025.
- Over 5 years, Cash from Financing Activities stood at $281.0 million in 2022, then sank by 119.57% to -$55.0 million in 2023, then surged by 92.73% to -$4.0 million in 2024, then sank by 8150.0% to -$330.0 million in 2025, then slumped by 54.55% to -$510.0 million in 2026.
- The last three Cash from Financing Activities figures came in at -$510.0 million (Q2 2026), -$133.0 million (Q1 2026), and -$330.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | -271.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -510.00 Mn |
| Mar 31, 2026 | -133.00 Mn |
| Dec 31, 2025 | -330.00 Mn |
| Sep 30, 2025 | -310.00 Mn |
| Jun 30, 2025 | -383.00 Mn |
| Dec 31, 2024 | -4.00 Mn |
| Sep 30, 2024 | -81.00 Mn |
| Jun 30, 2024 | -171.00 Mn |
| Mar 31, 2024 | -66.00 Mn |
| Dec 31, 2023 | -55.00 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Jun 30, 2023 | -145.00 Mn |
| Mar 31, 2023 | -21.00 Mn |
| Dec 31, 2022 | 281.00 Mn |
| Sep 30, 2022 | -12.00 Mn |
| Jun 30, 2022 | -188.00 Mn |
| Mar 31, 2022 | -89.00 Mn |
| Dec 31, 2021 | -33.00 Mn |
| Sep 30, 2021 | -14.00 Mn |
| Jun 30, 2021 | -73.00 Mn |